| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Evnin Luke is a Director, 10% Owner at SNDX, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 88 sales.
Our model assigns Evnin Luke a middling insider score of 56/100, based on 62 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -19.9%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 177,145 | $1.62 | $286,497.06 | -4.1% | -57.0% | - | |
| Mar 27, 2025 | HOWL Werewolf Therapeutics, Inc. | Director, 10% Owner | Sell | 2,425 | $1.05 | $2,546.25 | - | +11.7% | -27.0% | |
| May 4, 2021 | HOWL Werewolf Therapeutics, Inc. | Director, 10% Owner | Buy | 150,799 | $16.00 | $2,412,784.00 | +3.6% | +3.3% | -66.7% |